Homebiotech

biotech

biotech

Thalassaemia treatment gets EU approval

Jim Cornall - May 27, 2026

biotech

New data from Parkinson’s disease trial

Jim Cornall - May 27, 2026

biotech

Restoring the “longevity protein”

Jim Cornall - May 27, 2026

biotech

Positive topline results from phase 2 recurrent ovarian cancer trial

Jim Cornall - May 26, 2026

biotech

New options for lung cancer research with digital cell twin

Jim Cornall - September 22, 2025

biotech

Possible breakthrough in development of effective biomaterials

Jim Cornall - September 22, 2025

biotech

NeuroSense drug candidate shows benefit in Alzheimer’s

Jim Cornall - September 22, 2025

biotech

Base to Base biotech podcast 27: Childhood Cancer Awareness Month and DNA-based technology platforms

Jim Cornall - September 19, 2025

biotech

New biosensor detects viruses in the air

Jim Cornall - September 18, 2025

biotech

Cancer’s energy secrets could lead to new treatments

Jim Cornall - September 18, 2025

biotech

New Lithuanian oxygen sensors could lead to scientific breakthroughs

Jim Cornall - September 18, 2025

biotech

Galimedix Therapeutics completes phase 1 Alzheimer’s oral small molecule study

Jim Cornall - September 17, 2025

1...525354...79 Page 53 of 79

Stay Connected

- Advertisement -

spot_img

Latest Articles

biotech

Thalassaemia treatment gets EU approval

Jim Cornall - May 27, 2026 0

Agios Pharmaceuticals, Inc. has revealed that the European Commission has granted marketing authorisation for PYRUKYND (mitapivat), an oral pyruvate kinase (PK) activator, in adults...

New data from Parkinson’s disease trial

biotech Jim Cornall - May 27, 2026 0

Restoring the “longevity protein”

biotech Jim Cornall - May 27, 2026 0

Positive topline results from phase 2 recurrent ovarian cancer trial

biotech Jim Cornall - May 26, 2026 0

Rare oral cancer has distinct genetic profile

biotech Jim Cornall - May 26, 2026 0